Filter
883
Text search:
adverse
events
Featured
Recommendations
106
New Publications
189
Language
Document type
No document type
440
Guidelines
164
Studies & Reports
133
Manuals
64
Strategic & Response Plan
26
Training Material
22
Fact sheets
21
Situation Updates
5
Resource Platforms
4
Online Courses
2
Brochures
1
Infographics
1
Countries / Regions
Global
35
India
33
Western and Central Europe
24
South Africa
21
Kenya
18
Latin America and the Carribbean
17
Africa
17
Ghana
13
Ethiopia
12
Uganda
11
Philippines
11
Nepal
11
Nigeria
10
Tanzania
10
Eastern Europe
9
Syria
8
Bangladesh
8
Malawi
7
Ukraine
7
Rwanda
6
USA
5
South Sudan
5
Cambodia
5
South–East Asia Region
5
Sierra Leone
4
Namibia
4
Myanmar / Burma
4
Middle East and North Africa
4
Asia
4
Senegal
3
Pakistan
3
Zambia
3
Brazil
3
Lesotho
3
Guinea
2
Liberia
2
Congo, Democratic Republic of
2
Cameroon
2
Zimbabwe
2
Somalia
2
Germany
2
China
2
Indonesia
2
Mozambique
2
Sudan
2
Colombia
2
Botswana
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Other region
2
Venezuela
2
Russia
2
Burkina Faso
1
Mali
1
Niger
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Chad
1
Gambia
1
Mauritania
1
North Macedonia
1
Ecuador
1
El Salvador
1
Sri Lanka
1
Chile
1
East and Southern Africa
1
West and Central Africa
1
Bhutan
1
Laos
1
Canada
1
Tajikistan
1
Iran
1
Kyrgyzstan
1
Kazakhstan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
226
Clinical Guidelines
114
Key Resources
62
Public Health
56
Women & Child Health
50
Capacity Building
14
Pharmacy & Technologies
8
Toolboxes
Mental Health
106
COVID-19
83
TB
63
HIV
49
Planetary Health
45
Caregiver
34
Pharmacy
31
Conflict
29
NTDs
28
AMR
26
NCDs
22
Rapid Response
21
Disability
17
Global Health Education
17
Ebola & Marburg
13
Refugee
13
Specific Hazards
13
2.0 Rapid Response
13
Natural Hazards
12
Polio
5
Malaria
5
Zika
4
Health Financing Toolbox
4
Cholera
2
Social Ethics
2
Scoping Question: For adults and children living with HIV, which antiepileptic medications (such as phenobarbital, phenytoin, carbamazepine or valproic acid) produce benefits and/or harms when compared to a placebo or controls?
COVID-19 Vaccines: 1 Safety Surveillance 2 Manual
While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregn
...
Saving Lives Through Safe Surgery (SaLTS)
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform
...
A handbook for district and health facility staff
Schizophr Bull. 2014 Jan;40(1):192-213. doi: 10.1093/schbul/sbs150. Epub 2012 Dec 17.
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
A WHO-UNICEF joint statement encouraging greater health commodity supply chain integration for temperature-sensitive pharmaceuticals where appropriate, 19 November 2020
PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018
The Executive Board at its 150th session noted an earlier version of this report.1 The present report provides an update on the implementation of the Strategic Action Plan on Polio Transition (2018–2023)2 at the start of 2022, within the context of the coronavirus disease (COVID-19) pandemic.
This article was published on December 10, 2020, and updated on December 16, 2020, at NEJM.org. DOI: 10.1056/NEJMoa2034577
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir
...
The Lancet Regional Health Americas Volume 37100832 September 2024
This document facilitate the preparation of a risk communication and community engagement strategy for vaccination against COVID-19. Its goal is to help to strengthen the communication and planning capacities of the ministries or secretariats of health and other agencies in charge of communicating
...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti
...